Collaboration Formed to Develop New Radiochemicals for Diagnosing, Treating Brain Diseases
Feb 06, 2020 07:00 am | Patricia Inacio, PhD
A collaborative effort between Fuzionaire Diagnostics, McGill University and The Neuro (Montreal Neurological Institute-Hospital) will foster the development of a new class of radioactive molecules — called radiochemicals — for the diagnosis and treatment of neurodegenerative diseases, including Parkinson’s disease. Radiochemicals are compounds prepared with radioactive elements that are used for medical applications, such as […]
The post Collaboration Formed to Develop New Radiochemicals for Diagnosing, Treating Brain Diseases appeared first on Parkinson's News Today. |